Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Freemark

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|October 4, 2018
Determinants of Risk for Childhood ObesityMichael Freemark
Current Opinion in Endocrinology, Diabetes, and Obesity|October 12, 2011
Placental hormones and the control of maternal metabolism and fetal growthDorothee Newbern, Michael Freemark
Pediatric Endocrinology Reviews : PER|January 27, 2006
The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetesEvelyn Artz, Michael Freemark
Current Diabetes Reports|November 30, 2011
Pathogenesis and prevention of type 2 diabetes: parental determinants, breastfeeding, and early childhood nutritionSarah Bartz, Michael Freemark
Pediatric Endocrinology Reviews : PER|February 4, 2006
Anti-obesity medication use in adolescents: risks and benefitsMichael Freemark, Wieland Kiess
Current Opinion in Pediatrics|July 20, 2002
Thyroxine supplementation in preterm infants: critical analysisJon Oden, Michael Freemark
Diabetes Care|May 27, 2003
Screening for celiac disease in children with type 1 diabetes: two views of the controversyMichael Freemark, Lynne L Levitsky
Current Obesity Reports|October 21, 2020
Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient SelectionLaura C Page, Michael Freemark
Endocrinology and Metabolism Clinics of North America|August 9, 2005
Hormonal and metabolic consequences of childhood obesityEvelyn Artz, Andrea Haqq, Michael Freemark
Hormone Research|June 1, 2006
Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor IDon Fleenor, Ramamani Arumugam, Michael Freemark
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|October 4, 2018
Determinants of Risk for Childhood ObesityMichael Freemark
Current Opinion in Endocrinology, Diabetes, and Obesity|October 12, 2011
Placental hormones and the control of maternal metabolism and fetal growthDorothee Newbern, Michael Freemark
Pediatric Endocrinology Reviews : PER|January 27, 2006
The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetesEvelyn Artz, Michael Freemark
Current Diabetes Reports|November 30, 2011
Pathogenesis and prevention of type 2 diabetes: parental determinants, breastfeeding, and early childhood nutritionSarah Bartz, Michael Freemark
Pediatric Endocrinology Reviews : PER|February 4, 2006
Anti-obesity medication use in adolescents: risks and benefitsMichael Freemark, Wieland Kiess
Current Opinion in Pediatrics|July 20, 2002
Thyroxine supplementation in preterm infants: critical analysisJon Oden, Michael Freemark
Diabetes Care|May 27, 2003
Screening for celiac disease in children with type 1 diabetes: two views of the controversyMichael Freemark, Lynne L Levitsky
Current Obesity Reports|October 21, 2020
Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient SelectionLaura C Page, Michael Freemark
Endocrinology and Metabolism Clinics of North America|August 9, 2005
Hormonal and metabolic consequences of childhood obesityEvelyn Artz, Andrea Haqq, Michael Freemark
Hormone Research|June 1, 2006
Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor IDon Fleenor, Ramamani Arumugam, Michael Freemark
Pageof 7